Markets:

Overview

News

Currencies

International

Treasuries

Cardinal Health (NY:CAH)

221.34 -5.75 (-2.53%)

Streaming Delayed Price Updated: 3:58 PM EDT, Jul 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cardinal Health

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

19 20 Next >

Where Cardinal Health Stands With Analysts ↗

June 09, 2023

Via Benzinga

Cardinal Health's Outcomes Business Merges With Transaction Data Systems, Marking New Chapter ↗

June 05, 2023

Via Benzinga

7 Overvalued Blue-Chip Stocks to Sell Before June 2023 ↗

May 28, 2023

For a variety of reasons, there are several blue-chip stocks to avoid in this market. Here are seven overvalued blue-chip stocks to sell now.

Via InvestorPlace

Shhh! 3 Healthcare Stocks Quietly Hitting 52-Week Highs ↗

May 17, 2023

Investors are busy looking at tech stocks, but they should be looking for healthcare stocks to buy, as this group powers to new highs.

Via InvestorPlace

Chart Of The Day: Cardinal Health - The Right Prescription ↗

May 17, 2023

Revenue is expected to grow 12.60% this year and another 6.50% next year. Earnings are estimated to increase by 13.00% this year, and an additional 13.50% next year.

Via Talk Markets

Dividend Income Update April 2023 ↗

May 11, 2023

With May already underway it is time for all dividend income investors to look back at the previous month and see how much passive dividend income their portfolios generated.

Via Talk Markets

What 7 Analyst Ratings Have To Say About Cardinal Health ↗

April 26, 2023

Via Benzinga

The Latest Analyst Ratings for Cardinal Health ↗

March 22, 2023

Via Benzinga

After 300% Climb, McKesson Stock Earns Bullish Strength Rating ↗

May 10, 2023

McKesson stock rose in a steep upward incline from a low of 106.11 at the end of December 2018 to a 401.78 all-time high on Nov. 4 last year.

Via Investor's Business Daily

Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review ↗

May 05, 2023

The major indexes retreated for most of the week on banking fears,

Via Investor's Business Daily

Cardinal Health Q3 Earnings Beats Estimates On Pharmaceutical Segment Strength, Raises Annual Profit Forecast ↗

May 04, 2023

Via Benzinga

US Stocks Set For Mixed Open As Banking Jitters Dampen Apple Earnings Buzz: Analyst Advises 'Cautious Optimism' ↗

May 04, 2023

With so much going on in the banking space, sentiment continues to remain jittery. The index futures point to a mixed opening on Thursday, as the tech space exuded optimism ahead of Apple, Inc.’s...

Via Benzinga

7 Dividend Aristocrats to Buy for Long-Term Income ↗

April 28, 2023

These dividend aristocrats are the best stocks to buy for long-term income generation and lower portfolio risk.

Via InvestorPlace

Autolus Therapeutics Selects Cardinal Health as U.S. Commercial Distribution Partner

April 27, 2023

From Autolus Therapeutics plc

Via GlobeNewswire

AmerisourceBergen Stock Joins Elite Group Of Top Performers ↗

April 24, 2023

The 82 Relative Strength Rating shows that AmerisourceBergen stock outperformed 82% of all stocks over the past 12 months.

Via Investor's Business Daily

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 20, 2023

Via Benzinga

10 Best Performing Blue Chip Stocks ↗

April 14, 2023

While there may be varying interpretations among investors, the term “blue chip” typically denotes companies that are regarded as leaders in their respective fields.

Via Talk Markets

These 3 Health Care Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts ↗

April 12, 2023

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

McKesson Stock Strength Rating Jumps To 81; Strong Start To '23 ↗

April 07, 2023

McKesson stock shows rising price performance earning it an upgrade to its IBD Relative Strength Rating, from 73 to 81.

Via Investor's Business Daily

5 S&P 500 Stocks Showing Strength As Recession Fears Rise ↗

April 07, 2023

Medical stocks are holding up amid economic and market uncertainty.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023 ↗

March 31, 2023

Via Benzinga

This Dividend-Focused ETF Is Not a Good Dividend Investment ↗

March 30, 2023

Invesco Dividend Achievers ETF buys companies that reliably increase their dividends, which is also why it's not a great dividend investment.

Via The Motley Fool

Is It Too Late to Buy McKesson Stock? ↗

March 22, 2023

The healthcare supplier has seen its shares climb 15% over the past year.

Via The Motley Fool

Don't Wait for Your Dividends. Here's How You Can Collect Cash Every Month. ↗

March 22, 2023

These stocks all pay more than what you'd get with the average stock on the S&P 500.

Via The Motley Fool

3 Inflation-Resistant Businesses That Recently Raised Guidance ↗

March 21, 2023

These stocks can be relatively safe places to invest in if you're worried about inflation.

Via The Motley Fool

7 Stocks Set to Soar When the Market Recovers ↗

March 16, 2023

Daring contrarians can bid up the danger with these intriguing market ideas.

Via InvestorPlace

Healthcare Stocks With at Least 30 Years of Dividend Increases

March 14, 2023

Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield.

Via MarketBeat

Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?

March 01, 2023

By David Willey, Benzinga

Via TheNewswire.com

Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?

March 01, 2023

Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?

Via News Direct

Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? ↗

March 01, 2023

The medical device and supply manufacturing industry is focused on the design and production of medical instruments and devices.

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.